Bank Of New York Mellon Corp Cyteir Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.62 - $4.4 $40,508 - $110,022	-25,005 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$3.39 - $10.51 $26,628 - $82,556	7,855 Added 45.8%	25,005 $94,000
Q4 2021 Feb 11, 2022	BUY	$9.83 - $19.21 $14,735 - $28,795	1,499 Added 9.58%	17,150 $195,000
Q3 2021 Nov 12, 2021	BUY	$14.57 - $21.86 $228,035 - $342,130	15,651 New	15,651 $275,000

2.47M

Ticker CYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,413,400
Market Cap $107M
Description
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.